FDA — authorised 28 October 1982
- Application: BLA018780
- Marketing authorisation holder: LILLY
- Local brand name: HUMULIN R
- Indication: SOLUTION — SUBCUTANEOUS
- Status: approved
🇺🇸 regular human insulin in United States
FDA authorised regular human insulin on 28 October 1982
Marketing authorisations
FDA
- Status: approved
regular human insulin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is regular human insulin approved in United States?
Yes. FDA authorised it on 28 October 1982; FDA has authorised it.
Who is the marketing authorisation holder for regular human insulin in United States?
LILLY holds the US marketing authorisation.